Impeto Medical is set to showcase SUDOSCAN® and its significant role in quantitative sudomotor testing at the 17th annual conference of WoundHSI in New York on June 20-21, 2019. The diabetic foot is a costly complication of diabetes, both financially and personally, with a combination of neuropathy and peripheral artery disease that can lead to ulceration and limb loss. However, current foot screening recommendations detect diabetic complications too late in their course, and physicians often fail to comply with these guidelines.
Sudomotor nerves are autonomic fibers that innervate sweat glands and are affected early in diabetic neuropathy. Recent sudomotor testing methods are quick, quantitative, reproducible, and can detect the diabetic foot at risk early on. Furthermore, these methods can be implemented for routine clinical screening and accurate follow-up with minimal impact on the clinic's workflow. Impeto Medical will present clinical research data on sudomotor function testing for the diabetic foot, demonstrating the benefits of early detection and follow-up.